Related Experiment Video
Updated: Aug 15, 2026
08:19
Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
Conditional neutrality as a method of controlling tumour growth
1Allan Wilson Centre for Molecular Ecology and Evolution, Massey University, Private Bag 102904 North Shore Mail Centre, Albany AK 1310, New Zealand. p.r.smith@massey.ac.nz
Rivista Di Biologia
|September 24, 2005
Summary
This study proposes a novel cancer treatment strategy by exploiting tumor cell genetics. By making genes conditionally neutral, tumors may evolve dependence on supplements, enabling control through supplement removal.
Area of Science:
- Oncology
- Evolutionary Biology
- Genetics
Background:
- Tumors consist of rapidly dividing mutant cells.
- High mutation rates drive rapid evolution of tumor-promoting phenotypes like angiogenesis and metastasis.
- Existing treatments face challenges due to rapid tumor evolution and resistance.
Purpose of the Study:
- To propose a novel cancer treatment exploiting the genetic system of cancer cells.
- To investigate the potential of inducing conditional gene neutrality for tumor control.
- To explore the mechanisms of neutral evolution and genetic drift in cancer treatment.
Main Methods:
- Supplementing cancer cell populations with agents to render specific genes conditionally neutral.
- Leveraging neutral or near-neutral evolution and genetic drift for tumor-wide genetic modification.
- Analyzing factors influencing the fixation rate of conditionally neutral mutations.
- Estimating the time required for complete tumor cell dependence on supplementation.
Main Results:
- A theoretical framework for a novel cancer therapy based on induced genetic dependence.
- Identification of potential methods for mutation suppression in cancer cells.
- Analysis of factors affecting the speed and efficacy of the proposed treatment.
- Discussion of potential interactions with conventional cancer therapies.
Conclusions:
- Cancer cell genetic systems can be exploited for therapeutic purposes.
- Inducing conditional gene neutrality offers a potential strategy for tumor control.
- This approach may lead to a controllable tumor state through supplement withdrawal, potentially enhancing traditional therapies.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.